Advances in cervical cancer: current insights and future directions
Cancer Communications · 2025-02 · 45 (2) · 77-109
DOI: 10.1002/cac2.12629 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Communications, online erschienen am 29.11.2024. Verfasst von Miaochun Xu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, P. R. C…. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Papillomavirus Infections. Die Arbeit wurde bisher 171-mal zitiert (Crossref) und nennt 318 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Key R&D Program of China, Natural Science Foundation of China, Foundation of Tongji Hospital of HUST, China.
Abstract (Originalsprache)
In alignment with the World Health Organization's strategy to eliminate cervical cancer, substantial progress has been made in the treatment of this malignancy. Cervical cancer, largely driven by human papillomavirus (HPV) infection, is considered preventable and manageable because of its well‐established etiology. Advancements in precision screening technologies, such as DNA methylation triage, HPV integration detection, liquid biopsies, and artificial intelligence‐assisted diagnostics, have augmented traditional screening methods such as HPV nucleic acid testing and cytology. Therapeutic strategies aimed at eradicating HPV and reversing precancerous lesions have been refined as pivotal measures for disease prevention. The controversy surrounding surgery for early‐stage cervical cancer revolves around identifying optimal candidates for minimally invasive and conservative procedures without compromising oncological outcomes. Recent clinical trials have yielded promising results for the development of systemic therapies for advanced cervical cancer. Immunotherapies, such as immune checkpoint inhibitors (ICIs), antibody‐drug conjugates (ADCs), and targeted therapy have demonstrated significant effectiveness, marking a substantial advancement in cervical cancer management. Various combination therapies have been validated, and ongoing trials aim to enhance outcomes through the development of novel drugs and optimized combination regimens. The prospect of eradicating cervical cancer as the first malignancy to be eliminated is now within reach. In this review, we provide a comprehensive overview of the latest scientific insights, with a particular focus on precision managements for various stages of cervical disease, and explore future research directions in cervical cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, P. R. China.
- National Clinical Research Center for Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, P. R. China.
- Cancer Biology Research Center (Key Laboratory of the Ministry of Education), Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, P. R. China.
- Department of Gynecologic Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, P. R. China.
ORCID-Profile: Miaochun Xu, Canhui Cao, Peng Wu
Förderung
- National Key R&D Program of China
- Natural Science Foundation of China
- Foundation of Tongji Hospital of HUST, China
- National Key Research and Development Program of China
- National Natural Science Foundation of China
Zitieren
APA
Xu, M., Cao, C., Wu, P., Huang, X., & Ma, D. (2025). Advances in cervical cancer: current insights and future directions. Cancer Communications, 45(2), 77-109. https://doi.org/10.1002/cac2.12629
Vancouver
Xu M, Cao C, Wu P, Huang X, Ma D. Advances in cervical cancer: current insights and future directions. Cancer Communications. 2025;45(2):77-109. doi:10.1002/cac2.12629
BibTeX
@article{Xu2025,
author = {Xu, Miaochun and Cao, Canhui and Wu, Peng and Huang, Xiaoyuan and Ma, Ding},
title = {Advances in cervical cancer: current insights and future directions},
journal = {Cancer Communications},
year = {2025},
volume = {45},
number = {2},
pages = {77--109},
doi = {10.1002/cac2.12629}
}
EUVIMED